NO167511C - Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.

Info

Publication number
NO167511C
NO167511C NO883610A NO883610A NO167511C NO 167511 C NO167511 C NO 167511C NO 883610 A NO883610 A NO 883610A NO 883610 A NO883610 A NO 883610A NO 167511 C NO167511 C NO 167511C
Authority
NO
Norway
Prior art keywords
tieno
preparation
therapeutic active
active substituted
analogy procedure
Prior art date
Application number
NO883610A
Other languages
English (en)
Norwegian (no)
Other versions
NO883610L (no
NO167511B (no
NO883610D0 (no
Inventor
Hans-Jochen Lang
Klaus Weidmann
Karl-Heinz Scheunemann
Andreas W Herling
Robert Rippel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883610D0 publication Critical patent/NO883610D0/no
Publication of NO883610L publication Critical patent/NO883610L/no
Publication of NO167511B publication Critical patent/NO167511B/no
Publication of NO167511C publication Critical patent/NO167511C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO883610A 1987-08-15 1988-08-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater. NO167511C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3727244 1987-08-15
DE3744022 1987-12-24
DE3816996 1988-05-19

Publications (4)

Publication Number Publication Date
NO883610D0 NO883610D0 (no) 1988-08-12
NO883610L NO883610L (no) 1989-02-16
NO167511B NO167511B (no) 1991-08-05
NO167511C true NO167511C (no) 1991-11-13

Family

ID=27196347

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883610A NO167511C (no) 1987-08-15 1988-08-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.

Country Status (15)

Country Link
EP (1) EP0304732A3 (fr)
JP (1) JPS6470492A (fr)
KR (1) KR890003772A (fr)
CN (1) CN1029973C (fr)
CA (1) CA1268461A (fr)
DE (1) DE3827276A1 (fr)
DK (1) DK454588A (fr)
FI (1) FI89602C (fr)
HU (1) HU208539B (fr)
IL (1) IL87428A (fr)
MA (1) MA21352A1 (fr)
NO (1) NO167511C (fr)
NZ (1) NZ225805A (fr)
PT (1) PT88258B (fr)
TN (1) TNSN88083A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI885878A (fi) * 1987-12-22 1989-06-23 Hoechst Ag Substituerade tienoimidazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning som inhibitorer vid avsoendring av magsyra.
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
CN108191745A (zh) * 2018-01-08 2018-06-22 滁州学院 2-羟甲基-3,4-二甲氧基吡啶的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8417171D0 (en) * 1984-07-05 1984-08-08 Beecham Group Plc Compounds
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
EP0234485B1 (fr) * 1986-02-20 1992-04-01 Hoechst Aktiengesellschaft Dérivés substitués du thiénoimidazole, procédés pour leur préparation, compositions pharmaceutiques les contenant et leur application comme inhibiteurs de la sécrétion du suc gastrique
JP2662754B2 (ja) * 1992-07-20 1997-10-15 新日本製鐵株式会社 タンク底板溶接用裏当て鋼材およびタンク底板の防食方法

Also Published As

Publication number Publication date
DK454588D0 (da) 1988-08-12
NO883610L (no) 1989-02-16
EP0304732A3 (fr) 1990-06-13
FI89602C (fi) 1993-10-25
CA1268461A (fr) 1990-05-01
IL87428A (en) 1993-01-31
CN1032340A (zh) 1989-04-12
JPS6470492A (en) 1989-03-15
NO167511B (no) 1991-08-05
TNSN88083A1 (fr) 1990-07-10
FI89602B (fi) 1993-07-15
KR890003772A (ko) 1989-04-18
HUT50480A (en) 1990-02-28
PT88258B (pt) 1995-05-04
PT88258A (pt) 1989-06-30
DE3827276A1 (de) 1989-03-23
HU208539B (en) 1993-11-29
EP0304732A2 (fr) 1989-03-01
MA21352A1 (fr) 1989-04-01
DK454588A (da) 1989-02-16
FI883738A0 (fi) 1988-08-11
FI883738A (fi) 1989-02-16
CN1029973C (zh) 1995-10-11
IL87428A0 (en) 1989-01-31
NO883610D0 (no) 1988-08-12
NZ225805A (en) 1991-01-29

Similar Documents

Publication Publication Date Title
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO164542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater.
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO167028C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)pyrimidinderivater
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO893768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.